This study, funded by Boston Scientific, is underway to better understand real-world outcomes of the Vertiflex® Procedure in routine clinical practice. The Vertiflex® Procedure uses the Superion® Indirect Decompression System (IDS), a medical device approved for commercial use by the Food and Drug Administration (FDA) in the
United States for treatment of moderate lumbar spinal stenosis.